title: Practice guidelines for the implementation of a quality program in thromboprophylaxis and treatment management in patients with venous thromboembolic disease.
abstract: BACKGROUND
  Venous thromboembolic disease is a major cause of morbidity and hospital mortality worldwide. Although exact figures are unknown in Mexico, achieving uniformity of criteria among the specialties involved in the prophylaxis and treatment will offer a clearer picture and contribute to a more rational and interdisciplinary approach in order to improve the quality of care for patients and increase the level of awareness of this entity.
  
  
  CONCLUSIONS
  For the preparation of this document, a total of 11 medical specialists from Mexico City and the interior of the country met along with a highly experienced professional from Chicago, IL, USA with wide experience in the field and knowledge of methodology for the development of a management algorithm for prophylaxis in at-risk patients of venous thromboembolic disease. The expert group met in plenary working sessions, managed uniform criteria and reached consensus agreement by issuing a series of useful recommendations for the care of patients with venous thromboembolism in Mexican hospitals.
  
  
  CONCLUSIONS
  In Mexico there is the need to develop and disseminate guidelines on thromboprophylaxis and treatment of venous thromboembolic disease because of the wide disparity of views or simple misinformation, leading to diagnostic and treatment behaviors unique to each institution.
authors.affiliation: Unidad de Terapia Intensiva, Fundación Clínica Médica Sur, Tlalpan, DF, Mexico. revistacma95@yahoo.com.mx
authors.forename: Raúl
authors.initials: R
authors.lastname: Carrillo-Esper
authors.forename: Ernesto
authors.initials: E
authors.lastname: Alcántar-Luna
authors.forename: Martín Alberto
authors.initials: MA
authors.lastname: Herrera-Cornejo
authors.forename: David
authors.initials: D
authors.lastname: Jaimovich
authors.forename: Marco Antonio
authors.initials: MA
authors.lastname: Ramos-Corrales
authors.forename: Asisclo
authors.initials: A
authors.lastname: Villagómez-Ortiz
mesh_terms: D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use; D019468:Disease Management; D011307:Drug Prescriptions / Q000592:standards; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use; D006753:Hospital Records / Q000592:standards; D006801:Humans; D048228:Intermittent Pneumatic Compression Devices; D007755:Laboratories, Hospital / Q000592:standards; D008800:Mexico / Q000453:epidemiology; D016134:Organizational Policy; D019990:Perioperative Care / Q000592:standards; D011183:Postoperative Complications / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D011785:Quality Assurance, Health Care / Q000458:organization & administration*; D019984:Quality Indicators, Health Care; D011872:Radiology Department, Hospital / Q000592:standards; D018570:Risk Assessment; D053828:Stockings, Compression; D016306:Vena Cava Filters; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents